The primary objectives of this study were to assess the efficacy and safety of duloxetine for
reducing pain severity in fibromyalgia patients with or without current major depressive …

Objective: To investigate the efficacy of duloxetine in the treatment of pain and improvement
in functional impairment and quality of life in patients with fibromyalgia from a pooled …

Objective To assess the efficacy and safety of duloxetine, a serotonin and norepinephrine
reuptake inhibitor, in subjects with primary fibromyalgia, with or without current major …

Objective: Assess the efficacy of duloxetine 60/120 mg (N= 162) once daily compared with
placebo (N= 168) in the treatment of patients with fibromyalgia, during six months of …

This was a 12-week, randomized, double-blind, placebo-controlled trial to assess the
efficacy and safety of duloxetine, a selective serotonin and norepinephrine reuptake …

Objective. To investigate the efficacy of flexible dose duloxetine 60–120 mg/day on changes
in fibromyalgia (FM) symptoms assessed by the Patient Global Impression of Improvement …

Background: To assess the efficacy (in particular, in pain, functional impairment, and quality
of life) and safety and tolerability (incidence of adverse events, discontinuation rates …

The objective of this paper is to better understand the relationship of pain and mood in
patients with fibromyalgia and comorbid major depressive disorder (MDD). Pooled data from …

Objective. To review the use of duloxetine, a new selective serotonin and norepinephrine
reuptake inhibitor (SNRI), and other antidepressants in the treatment of patients with …

Background: Despite treatment advances, major depressive disorder (MDD) is still a
significant cause of morbidity and mortality. Current therapies frequently fall short of …